Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
1.060
-0.050 (-4.50%)
At close: Apr 28, 2026, 4:00 PM EDT
1.060
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:21 PM EDT
Haoxi Health Technology Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Revenue | 42.68 | 32.8 | 48.52 | 28.23 | 16.16 | 12.85 |
| Revenue Growth (YoY) | -12.85% | -32.39% | 71.88% | 74.72% | 25.76% | - |
| Cost of Revenue | 40.63 | 31.88 | 45.77 | 26.17 | 15.51 | 12.24 |
| Gross Profit | 2.04 | 0.93 | 2.75 | 2.06 | 0.65 | 0.61 |
| Selling, General & Admin | 9.52 | 2.85 | 0.95 | 0.81 | 0.28 | 0.21 |
| Research & Development | 0.07 | 0.08 | 0.08 | 0.06 | 0.1 | 0.06 |
| Operating Expenses | 9.6 | 2.93 | 1.03 | 0.87 | 0.38 | 0.28 |
| Operating Income | -7.55 | -2 | 1.72 | 1.2 | 0.27 | 0.33 |
| Interest Expense | -0.05 | -0.05 | -0.04 | -0.02 | -0.01 | -0 |
| Interest & Investment Income | 0.27 | 0.36 | 0.08 | - | - | - |
| Other Non Operating Income (Expenses) | 5.83 | 5.83 | -0.02 | 0.02 | 0 | -0 |
| Pretax Income | -2.4 | 4.15 | 1.74 | 1.19 | 0.26 | 0.33 |
| Income Tax Expense | 0.38 | 0.27 | 0.44 | 0.22 | 0.02 | 0.02 |
| Net Income | -2.77 | 3.88 | 1.29 | 0.97 | 0.24 | 0.3 |
| Net Income to Common | -2.77 | 3.88 | 1.29 | 0.97 | 0.24 | 0.3 |
| Net Income Growth | - | 200.13% | 33.20% | 296.49% | -19.56% | - |
| Shares Outstanding (Basic) | 5 | 2 | 1 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 5 | 2 | 1 | 1 | 1 | 1 |
| Shares Change (YoY) | 577.16% | 95.84% | 10.82% | 10.45% | - | - |
| EPS (Basic) | -0.61 | 1.66 | 1.06 | 0.88 | 0.24 | 0.30 |
| EPS (Diluted) | -0.77 | 1.32 | 1.06 | 0.87 | 0.24 | 0.30 |
| EPS Growth | - | 25.32% | 21.30% | 255.70% | -19.56% | - |
| Free Cash Flow | -3.37 | -3.36 | -0.8 | -0.92 | -0.68 | 2.65 |
| Free Cash Flow Per Share | -0.74 | -1.40 | -0.66 | -0.83 | -0.68 | 2.65 |
| Gross Margin | 4.79% | 2.83% | 5.67% | 7.31% | 4.01% | 4.71% |
| Operating Margin | -17.70% | -6.10% | 3.54% | 4.24% | 1.66% | 2.57% |
| Profit Margin | -6.49% | 11.82% | 2.66% | 3.44% | 1.51% | 2.37% |
| Free Cash Flow Margin | -7.90% | -10.24% | -1.65% | -3.25% | -4.23% | 20.59% |
| EBITDA | -7.05 | -1.71 | 1.73 | 1.2 | 0.27 | 0.33 |
| EBITDA Margin | -16.52% | -5.20% | 3.56% | 4.27% | 1.68% | 2.58% |
| D&A For EBITDA | 0.5 | 0.29 | 0.01 | 0.01 | 0 | 0 |
| EBIT | -7.55 | -2 | 1.72 | 1.2 | 0.27 | 0.33 |
| EBIT Margin | -17.70% | -6.10% | 3.54% | 4.24% | 1.66% | 2.57% |
| Effective Tax Rate | - | 6.53% | 25.56% | 18.54% | 5.78% | 6.52% |
Source: S&P Capital IQ. Standard template.
Financial Sources.